KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)

Ginkgo Bioworks Holdings filings provide 4 years of Interest Expenses readings, the most recent being $31.4 million for Q4 2024.

  • On a quarterly basis, Interest Expenses fell 28.72% to $31.4 million in Q4 2024 year-over-year; TTM through Sep 2025 was $31.4 million, a 28.34% increase, with the full-year FY2024 number at $94000.0, up 1.08% from a year prior.
  • Interest Expenses hit $31.4 million in Q4 2024 for Ginkgo Bioworks Holdings, up from -$9.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $44.0 million in Q4 2023 to a low of -$15.0 million in Q3 2023.
  • Median Interest Expenses over the past 4 years was $570500.0 (2020), compared with a mean of $2.9 million.
  • The widest YoY moves for Interest Expenses: up 38.41% in 2024, down 28.72% in 2024.
  • Ginkgo Bioworks Holdings' Interest Expenses stood at $590000.0 in 2020, then dropped by 6.61% to $551000.0 in 2021, then skyrocketed by 7886.75% to $44.0 million in 2023, then dropped by 28.72% to $31.4 million in 2024.
  • The last three reported values for Interest Expenses were $31.4 million (Q4 2024), -$9.3 million (Q3 2024), and -$10.3 million (Q2 2024) per Business Quant data.